Expression of UCP2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

被引：0
|
作者：
Imai, K. [1 ]
Fukuda, T. [1 ]
Wada, T. [1 ]
Kawanishi, M. [1 ]
Tasaka, R. [1 ]
Nishimura, S. [2 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Obstet & Gynecol, Osaka, Japan
[2] Kishiwada City Hosp, Obstet & Gynecol, Kishiwada, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0310
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [1] UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer
    Imai, Kenji
    Fukuda, Takeshi
    Wada, Takuma
    Kawanishi, Masaru
    Tasaka, Reiko
    Yasui, Tomoyo
    Sumi, Toshiyuki
    [J]. ONCOLOGY LETTERS, 2017, 14 (01) : 951 - 957
  • [2] EXPRESSION OF SIRTUIN 1 PREDICTS THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED UTERINE CERVICAL CANCER
    Yamauchi, M.
    Fukuda, T.
    Wada, T.
    Kawanishi, M.
    Imai, K.
    Teramae, M.
    Tasaka, R.
    Kasai, M.
    Hashiguchi, Y.
    Ichimura, T.
    Yasui, T.
    Sumi, T.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 545 - 545
  • [3] EXPRESSION OF EGFL7 PREDICTS THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED UTERINE CERVICAL CANCER
    Yamauchi, M.
    Fukuda, T.
    Wada, T.
    Kawanishi, M.
    Imai, K.
    Tasaka, R.
    Yasui, T.
    Deguchi, M.
    Sumi, T.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 172 - 172
  • [4] Sirtuin1 expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer
    Teramae, Masatomo
    Fukuda, Takeshi
    Wada, Takuma
    Kawanishi, Masaru
    Imai, Kenji
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (01) : 73 - 78
  • [5] Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer
    Morishita, Masanari
    Sumi, Toshiyuki
    Nakano, Yusuke
    Teramae, Masatomo
    Fukuda, Takeshi
    Nobeyama, Hiroyuki
    Yoshida, Hiroyuki
    Matsumoto, Yoshinari
    Yasui, Tomoyo
    Ishiko, Osamu
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (02) : 341 - 346
  • [6] PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer
    Shimomura, Masahiro
    Fukuda, Takeshi
    Awazu, Yuichiro
    Nanno, Shigenori
    Inoue, Yuta
    Matsubara, Hiroaki
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    [J]. ONCOLOGY LETTERS, 2021, 21 (02)
  • [7] XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer
    Wada, Takuma
    Fukuda, Takeshi
    Shimomura, Masahiro
    Inoue, Yuta
    Kawanishi, Masaru
    Tasaka, Reiko
    Yasui, Tomoyo
    Ikeda, Kazuo
    Sumi, Toshiyuki
    [J]. ONCOLOGY LETTERS, 2018, 15 (03) : 3766 - 3771
  • [8] NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER
    Mousavi, A.
    Mousavi, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [9] NEOADJUVANT CHEMOTHERAPY OF LOCALLY ADVANCED CERVICAL CANCER
    Kuznetsova, O.
    Rybin, A.
    Dubynina, V.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [10] Neoadjuvant chemotherapy for locally advanced cervical cancer
    Takashi Iwata
    Azumi Miyauchi
    Yukako Suga
    Hiroshi Nishio
    Masaru Nakamura
    Akiko Ohno
    Nobumaru Hirao
    Tohru Morisada
    Kyoko Tanaka
    Hiroki Ueyama
    Hidemichi Watari
    Daisuke Aoki
    [J]. Chinese Journal of Cancer Research, 2016, 28 (02) : 235 - 240
12345